⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SXTPW News
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
globenewswire.com
SXTPW
SXTP
60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
globenewswire.com
SXTPW
SXTP
Form 8-K
sec.gov
SXTPW
SXTP
Form 8-K
sec.gov
SXTPW
SXTP
Form 8-K
sec.gov
SXTP
SXTPW
Form 8-K
sec.gov
SXTPW
SXTP
Form 8-K
sec.gov
SXTP
SXTPW
Form 8-K
sec.gov
SXTP
SXTPW
Form 8-K
sec.gov
SXTP
SXTPW
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
globenewswire.com
SXTPW
SXTP